News

Jeremy Herskowitz, Ph.D., professor in the Department of Neurology, has been named the latest recipient of the school's Featured Discovery award. This recognition celebrates notable faculty research contributions and highlights the impact of their scientific advancements.

Eleven faculty members in the UAB Department of Neurology have been promoted effective Oct. 1, 2026.

UAB’s new Clinical Trialist Development Program (CTDP) has selected 24 Heersink applicants for its 2026-2027 cohort. The program will provide these candidates with training, mentorship, and salary support to lead industry-sponsored clinical trials. It will also supply them with a 20% protected time allowance, allowing them to dedicate more time to research.

When David Standaert, M.D., Ph.D., flew to Birmingham from Boston to present a Grand Rounds at UAB in the fall of 2005, he did not know at the time that it would mark the beginning of a 21-year-long career trajectory defined by growth, innovation, and an enduring investment in the people and programs that would shape the future of neurology at UAB.

Erik Roberson, M.D., Ph.D., has been named interim chair of the UAB Department of Neurology, effective Oct. 1, 2026.

With a career distinguished by expertise in neuromuscular and autonomic disorders, the development of innovative clinical programs, and a commitment to advancing patient care and research, Mohamed Kazamel, M.D., credits UAB Neurology with providing the foundation for his professional growth.

Twenty-three Heersink School of Medicine faculty were recognized Sept. 22 for their appointment to endowed chairs and professorships during a special reception.

The UAB Department of Orthopaedic Surgery, in collaboration with the departments of Neurosurgery, Neurology, and Surgery, has launched a new Peripheral Nerve Clinic to address the complex needs of patients with serious nerve injuries.

The UAB Genomic Medicine Research and Implementation Training Program, led by Nita Limdi, Pharm.D., Ph.D., MSPH, professor in the Department of Neurology and associate dean for Genomic Medicine in the Heersink School of Medicine, has been renewed for an additional five years, extending support through 2031.

UAB researchers Abhishek Guha, Ph.D., and Peter H. King, M.D., in the Department of Neurology, have received a multi-PI R01 research award from the NIH's National Institute of Neurological Disorders and Stroke to investigate novel molecular mechanisms underlying the development and persistence of pain after acute peripheral injury.

A landmark UAB-led trial found that restoring blood flow through carotid revascularization does not improve cognition in patients with asymptomatic carotid artery stenosis, providing important insights for stroke prevention and patient care.

Roxanne Lockhart, M.D., recently joined the UAB Department of Neurology as an assistant professor in the Division of Epilepsy, bringing a rich history of connection and dedication to the institution.

UAB researchers are part of an international study investigating a drug that could potentially stop or slow bleeding in the brain, also known as an intracerebral hemorrhage. Caused by the rupture of a blood vessel in the brain, intracerebral hemorrhage is the second leading cause of stroke, responsible for up to 30 percent of all strokes.

The UAB Medicine Leadership Development Office (LDO) recently recognized 14 individuals in its ninth cohort of Sharing Authentically to Inspire and Lead (SAIL). The fall 2026 graduates received their certificates on Sept. 1.

Marissa Natelson Love, M.D., associate professor in the UAB Department of Neurology, has been selected as a recipient of the Association of Academic Leaders of Neurology (AALN) Faculty Leadership Award.

The UAB Department of Neurology is proud to recognize Aparna Vaddiparti, M.D., assistant professor, for completing the Center for Teaching and Learning’s (CTL) Essentials of Teaching program.

UAB researchers found that blocking sortilin binding significantly improves progranulin gene therapy for frontotemporal dementia, boosting protein delivery, reducing brain inflammation and advancing potential treatments for a disease with no cure.

Five Heersink faculty members have been named recipients of UAB’s Faculty Development Grants.

In the Department of Cell, Developmental, and Integrative Biology, Zhiyong Liu, Ph.D., assistant professor, is investigating one of the molecular control systems that keeps this cellular cleanup running.

Researchers at UAB have discovered a surprising modification that could make an emerging therapy for frontotemporal dementia (FTD) more effective, potentially helping guide the next generation of treatments for a devastating disease that currently has no cure.

Eight research teams have been selected as the inaugural recipients of the Heersink School of Medicine’s Team Science Grant Program. The funded teams will tackle a wide range of health challenges while laying the groundwork for future large-scale research initiatives.

UAB will help lead an NIH-funded Population Genomic Screening Network initiative to integrate genomic screening into primary care, enabling earlier detection of inherited cancer, cardiovascular and other genetic risks to improve prevention, health outcomes and equitable care.

A landmark Alzheimer's disease clinical trial has provided the strongest evidence to date that lowering the protein tau can slow cognitive decline in patients. The findings build on pioneering research published in Science in 2007 by UAB neurologist Erik D.

Long before neurology became an official department at UAB, it existed as something much less defined: a small but steadily growing field shaped by the efforts of a few providers working to meet a need that was becoming prevalent across the region.

UAB researchers report Phase 1 trial results showing a novel immunotherapy was well-tolerated and doubled the progression-free survival time in glioblastoma patients, offering new optimism for improving survival and quality of life.

William Meador, M.D., associate professor in the Department of Neurology, has been appointed vice chair for clinical affairs, a role that will help guide the department's clinical strategy and coordinate neurological care across UAB and UAB St. Vincent's.

The UAB Medicine Leadership Development Office (LDO) is proud to honor the latest graduates of the Emerging Leaders Series (ELS) — 24 accomplished professionals who represent the breadth and strength of our institution.

The statistics are startling: more than 7 million Americans age 65 and older are living with Alzheimer’s disease, a figure that is projected to double by 2060. In Alabama, over 103,000 people age 65 and older—nearly 12% of seniors—have been diagnosed with Alzheimer’s. Alabama has the sixth highest Alzheimer's disease mortality rate in the nation.

The renamed Frances Gorrie Alzheimer’s Disease Center at UAB will accelerate research, expand clinical trials, strengthen specialist training and improve dementia care across Alabama.

A $2.9M NIH grant aims to provide comprehensive genomic medicine consultations to healthcare providers in Alabama and Tennessee, helping integrate genetic and genomic insights into routine patient care.